These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 11279290)

  • 1. Direct determination of the N-acetyl-L-aspartate synthesis rate in the human brain by (13)C MRS and [1-(13)C]glucose infusion.
    Moreno A; Ross BD; Blüml S
    J Neurochem; 2001 Apr; 77(1):347-50. PubMed ID: 11279290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Magnetic resonance imaging in juvenile Canavan disease.
    Toft PB; Geiss-Holtorff R; Rolland MO; Pryds O; Müller-Forell W; Christensen E; Lehnert W; Lou HC; Ott D; Hennig J
    Eur J Pediatr; 1993 Sep; 152(9):750-3. PubMed ID: 8223809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppressing N-Acetyl-l-Aspartate Synthesis Prevents Loss of Neurons in a Murine Model of Canavan Leukodystrophy.
    Sohn J; Bannerman P; Guo F; Burns T; Miers L; Croteau C; Singhal NK; McDonough JA; Pleasure D
    J Neurosci; 2017 Jan; 37(2):413-421. PubMed ID: 28077719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo quantitation of cerebral metabolite concentrations using natural abundance 13C MRS at 1.5 T.
    Blüml S
    J Magn Reson; 1999 Feb; 136(2):219-25. PubMed ID: 9986765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of NAA-synthesis in the human brain in vivo: Canavan's disease, Alzheimer's disease and schizophrenia.
    Harris K; Lin A; Bhattacharya P; Tran T; Wong W; Ross B
    Adv Exp Med Biol; 2006; 576():263-73; discussion 361-3. PubMed ID: 16802718
    [No Abstract]   [Full Text] [Related]  

  • 6. Natural history of Canavan disease revealed by proton magnetic resonance spectroscopy (1H-MRS) and diffusion-weighted MRI.
    Janson CG; McPhee SW; Francis J; Shera D; Assadi M; Freese A; Hurh P; Haselgrove J; Wang DJ; Bilaniuk L; Leone P
    Neuropediatrics; 2006 Aug; 37(4):209-21. PubMed ID: 17177147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Magnetic resonance tomography and localized proton spectroscopy in 2 siblings with Canavan's disease].
    Engelbrecht V; Rassek M; Gärtner J; Kahn T; Mödder U
    Rofo; 1995 Sep; 163(3):238-44. PubMed ID: 7548871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Canavan disease. Analysis of the nature of the metabolic lesions responsible for development of the observed clinical symptoms.
    Baslow MH; Resnik TR
    J Mol Neurosci; 1997 Oct; 9(2):109-25. PubMed ID: 9407392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Restricted diffusion in Canavan disease.
    Srikanth SG; Chandrashekar HS; Nagarajan K; Jayakumar PN
    Childs Nerv Syst; 2007 Apr; 23(4):465-8. PubMed ID: 17219235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uncoupling N-acetylaspartate from brain pathology: implications for Canavan disease gene therapy.
    von Jonquieres G; Spencer ZHT; Rowlands BD; Klugmann CB; Bongers A; Harasta AE; Parley KE; Cederholm J; Teahan O; Pickford R; Delerue F; Ittner LM; Fröhlich D; McLean CA; Don AS; Schneider M; Housley GD; Rae CD; Klugmann M
    Acta Neuropathol; 2018 Jan; 135(1):95-113. PubMed ID: 29116375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-acetylaspartate supports the energetic demands of developmental myelination via oligodendroglial aspartoacylase.
    Francis JS; Wojtas I; Markov V; Gray SJ; McCown TJ; Samulski RJ; Bilaniuk LT; Wang DJ; De Vivo DC; Janson CG; Leone P
    Neurobiol Dis; 2016 Dec; 96():323-334. PubMed ID: 27717881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feeding versus infusion: a novel approach to study the NAA metabolism in rat brain.
    Karelson G; Ziegler A; Künnecke B; Seelig J
    NMR Biomed; 2003; 16(6-7):413-23. PubMed ID: 14679503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamic or inert metabolism? Turnover of N-acetyl aspartate and glutathione from D-[1-13C]glucose in the rat brain in vivo.
    Choi IY; Gruetter R
    J Neurochem; 2004 Nov; 91(4):778-87. PubMed ID: 15525331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel peak assignments of in vivo (13)C MRS in human brain at 1.5 T.
    Blüml S; Hwang JH; Moreno A; Ross BD
    J Magn Reson; 2000 Apr; 143(2):292-8. PubMed ID: 10729255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence supporting a role for N-acetyl-L-aspartate as a molecular water pump in myelinated neurons in the central nervous system. An analytical review.
    Baslow MH
    Neurochem Int; 2002 Apr; 40(4):295-300. PubMed ID: 11792458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 1-(13)C glucose magnetic resonance spectroscopy of pediatric and adult brain disorders.
    Blüml S; Moreno A; Hwang JH; Ross BD
    NMR Biomed; 2001 Feb; 14(1):19-32. PubMed ID: 11252037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measuring N-acetylaspartate synthesis in vivo using proton magnetic resonance spectroscopy.
    Xu S; Yang J; Shen J
    J Neurosci Methods; 2008 Jul; 172(1):8-12. PubMed ID: 18486230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced glutamate neurotransmission in patients with Alzheimer's disease -- an in vivo (13)C magnetic resonance spectroscopy study.
    Lin AP; Shic F; Enriquez C; Ross BD
    MAGMA; 2003 Feb; 16(1):29-42. PubMed ID: 12695884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Canavan's spongiform leukodystrophy: a clinical anatomy of a genetic metabolic CNS disease.
    Baslow MH
    J Mol Neurosci; 2000 Oct; 15(2):61-9. PubMed ID: 11220786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-acetyl-L-aspartic acid: a literature review of a compound prominent in 1H-NMR spectroscopic studies of brain.
    Birken DL; Oldendorf WH
    Neurosci Biobehav Rev; 1989; 13(1):23-31. PubMed ID: 2671831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.